1. Home
  2. SFST vs STRO Comparison

SFST vs STRO Comparison

Compare SFST & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern First Bancshares Inc.

SFST

Southern First Bancshares Inc.

HOLD

Current Price

$58.03

Market Cap

527.0M

Sector

Finance

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$29.63

Market Cap

524.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFST
STRO
Founded
1999
2003
Country
United States
United States
Employees
N/A
133
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
527.0M
524.8M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SFST
STRO
Price
$58.03
$29.63
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$64.00
$31.33
AVG Volume (30 Days)
113.7K
281.6K
Earning Date
04-21-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
94.76
N/A
EPS
1.19
N/A
Revenue
$6,282,000.00
N/A
Revenue This Year
$10.47
N/A
Revenue Next Year
$12.19
N/A
P/E Ratio
$49.14
N/A
Revenue Growth
12.99
N/A
52 Week Low
$35.36
$0.67
52 Week High
$62.38
$43.85

Technical Indicators

Market Signals
Indicator
SFST
STRO
Relative Strength Index (RSI) 49.19 50.77
Support Level $53.96 $23.53
Resistance Level $58.43 $30.94
Average True Range (ATR) 1.91 2.89
MACD -0.16 0.40
Stochastic Oscillator 30.83 76.63

Price Performance

Historical Comparison
SFST
STRO

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. Through its banking subsidiary, it is engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer, and mortgage loans, ATM processing, and other banking products and services to the general public. The group operates through various retail offices located in the Greenville, Columbia, and Charleston markets of South Carolina, three retail offices in the Raleigh, Greensboro, and Charlotte markets of North Carolina, and one retail office in Atlanta, Georgia.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: